Show HN: iOS App Size Analysis Tool for macOS (apps.apple.com)
2 points by elpakal 3h ago 0 comments
Show HN: LocoStudio - A better UI for Ollama (locostudio.ai)
5 points by simmy345 17h ago 0 comments
Pliant Therapeutics Bay Area biotech company announces layoffs
1 randycupertino 1 5/6/2025, 11:28:25 PM kron4.com ↗
https://ir.pliantrx.com/news-releases/news-release-details/p...
> SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that following a prespecified data review and recommendation by the trial’s independent Data Safety Monitoring Board (DSMB), as well as a secondary review and recommendation by an outside expert panel, Pliant has discontinued the BEACON-IPF Phase 2b trial evaluating bexotegrast in patients with idiopathic pulmonary fibrosis (IPF). While an imbalance in unadjudicated IPF-related adverse events between the treatment and placebo groups led to the discontinuation of the trial, early evidence of efficacy on the forced vital capacity (FVC) endpoint was also observed.
> BEACON-IPF is the first late-stage IPF trial to be discontinued for safety while showing strong evidence of efficacy.